Sionna Therapeutics, Inc.
SION
$39.46
$0.451.15%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.23% | -9.62% | -4.00% | 37.71% | -197.49% |
| Total Depreciation and Amortization | 28.57% | -7.55% | -4.79% | -1.18% | 1.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 36.78% | 14.62% | 147.12% | -91.66% | 2,458.10% |
| Change in Net Operating Assets | 179.26% | -29.30% | -159.09% | 299.49% | 25.74% |
| Cash from Operations | 16.10% | -11.45% | -38.26% | 33.39% | -74.33% |
| Capital Expenditure | -- | 100.00% | -218.52% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 199.76% | 83.53% | -1,025.00% | 46.58% | 136.36% |
| Cash from Investing | 199.38% | 83.54% | -1,027.20% | 46.32% | 136.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 809,456.00% | -65.75% | 92.11% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -34.05% | -- |
| Cash from Financing | 732.69% | -100.15% | 14,474.22% | -41.37% | -2,721.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 123.61% | -192.88% | 2,102.40% | 124.64% | 78.63% |